Cluster ID,Predicted General Cell Type,Predicted Detailed Cell Type,Possible Mixed Cell Types,Marker Number,Marker List,Iterations,Model,Provider,Tissue,Species,Additional Info,Conversation History
"cd8-positive, alpha-beta t cell",Cytotoxic Lymphocytes,"Activated Cytotoxic T Cells (CD8+ T cells and/or γδ T cells) with NK-like features, Natural Killer (NK) Cells, NKT-like Cells or Innate Lymphoid Cells (ILC1)","Activated Cytotoxic T Lymphocytes, specifically a population enriched for CD8+ T cells and/or γδ T cells, exhibiting a strong effector/cytotoxic phenotype and potentially some NK-like receptor expression.",50,"KLRC2, XCL2, LINC02446, CRTAM, KLRK1, KLRC4, KLRD1, XCL1, GZMH, CD160, CD8B, NKG7, GZMA, GZMB, GZMK, CD8A, TRGC2, SLA2, TIGIT, TNFRSF9, GPR18, CCL4, PRF1, ATP8B4, APBA2, CCL4L2, DUSP4, CTSW, TMIGD2, TRGC1, CCL5, ABI3, IL21R, IFNG, CD7, CLIC3, ENTPD1, LDLRAD4, PTPN22, HOPX, GZMM, CST7, PARD6G, ZEB2, SH2D1A, LAYN, LAG3, PRKCH, AOAH, IKZF2",1,google/gemini-2.5-flash,openrouter,large intestine,human,N/A,"Final Annotation Agent: Here's a detailed analysis to identify the cell type based on the provided marker list: **Step 1: List the Key Functional Markers** This list is rich in genes associated with cytotoxic function and immune regulation. * **Cytotoxicity & Granule-associated proteins:** * **GZMH, GZMA, GZMB, GZMK:** Granzymes are serine proteases found in the granules of cytotoxic T lymphocytes (CTLs) and natural killer (NK) cells. They induce target cell apoptosis. GZMB is particularly potent. * **PRF1 (Perforin 1):** A pore-forming protein essential for the delivery of granzymes into target cells, leading to their lysis. * **NKG7:** A transmembrane protein found in the granules of NK cells and CTLs, involved in granule exocytosis. * **CTSW (Cathepsin W):** A cysteine protease expressed in NK cells and CTLs, potentially involved in granule maturation or function. * **Chemokines & Cytokines:** * **XCL2, XCL1:** Lymphotactin (XCL1/XCL2) are C-chemokines primarily expressed by NK cells and cytotoxic T cells, attracting other immune cells. * **CCL4, CCL4L2, CCL5:** Chemokine (C-C motif) ligand 4, 4-like 2, and 5 (RANTES). These are potent chemoattractants for various immune cells, including NK cells, T cells, and monocytes, often upregulated during immune responses. * **IFNG (Interferon-gamma):** A crucial cytokine produced by NK cells and T cells, particularly Th1 and cytotoxic T cells, with potent antiviral, anti-tumor, and immunomodulatory effects. * **IL21R (Interleukin 21 Receptor):** While a receptor, its presence suggests responsiveness to IL-21, a cytokine important for NK and T cell activation and differentiation. * **Immune Checkpoint & Co-stimulatory Molecules:** * **TIGIT (T cell immunoreceptor with Ig and ITIM domains):** An inhibitory receptor expressed on NK cells and T cells, involved in immune suppression. * **LAG3 (Lymphocyte-activation gene 3):** Another inhibitory receptor expressed on activated T cells and NK cells, contributing to immune exhaustion. * **TNFRSF9 (CD137/4-1BB):** A co-stimulatory receptor expressed on activated T cells and NK cells, promoting their survival and proliferation. * **Other Immune-related:** * **GPR18:** A G protein-coupled receptor expressed on immune cells, potentially involved in immune regulation. * **PTPN22:** A protein tyrosine phosphatase involved in regulating T cell activation. * **SH2D1A:** Involved in NK cell and T cell signaling, mutations are associated with X-linked lymphoproliferative disease. * **ABI3:** An adaptor protein involved in immune cell signaling. * **DUSP4:** A dual-specificity phosphatase, often involved in regulating MAPK signaling in immune cells. **Step 2: List the Key Cell Type Markers** This list strongly points towards cytotoxic lymphocytes, specifically NK cells and cytotoxic T cells. * **Natural Killer (NK) Cell Markers:** * **KLRC2 (NKG2C), KLRK1 (NKG2D), KLRC4 (NKG2D ligand), KLRD1 (CD94):** These are members of the C-type lectin-like receptor family, characteristic of NK cells. NKG2C and NKG2D are activating receptors, while CD94 forms a heterodimer with NKG2A (inhibitory) or NKG2C (activating). * **CD160:** A receptor expressed on NK cells and some T cells, involved in NK cell activation. * **CRTAM:** A cell surface receptor expressed on NK cells and some T cells, involved in cell-cell adhesion and immune synapse formation. * **NKG7:** (Also listed under functional markers) A granular protein highly characteristic of NK cells and cytotoxic T cells. * **Cytotoxic T Lymphocyte (CTL) Markers:** * **CD8B, CD8A:** Components of the CD8 co-receptor, defining cytotoxic T lymphocytes (CTLs). * **TRGC2, TRGC1:** T cell receptor gamma chain constant regions, indicating the presence of gamma-delta (γδ) T cells. * **General Lymphocyte/Immune Cell Markers:** * **CD7:** A pan-T cell marker, also expressed on NK cells and some B cell precursors. * **LINC02446:** A long intergenic non-coding RNA, its specific cell type association needs further investigation but often co-expressed with immune genes. * **ATP8B4, APBA2, ENTPD1, LDLRAD4, HOPX, CST7, PARD6G, ZEB2, LAYN, PRKCH, AOAH, IKZF2:** While some of these genes have broader expression, their co-expression in this context might indicate specific immune cell states or functions. For example, CST7 (Cystatin F) is found in cytotoxic granules. ZEB2 is a transcription factor involved in NK cell development and function. IKZF2 (Helios) is a transcription factor often associated with regulatory T cells, but also found in activated effector T cells. **Step 3: Cross-reference Known Databases** A quick mental cross-reference with common scRNA-seq atlases (e.g., Human Cell Atlas, specific immune cell atlases) and literature confirms the strong association of these markers with cytotoxic lymphocytes. * **NK cells:** KLRC2, KLRK1, KLRD1, CD160, XCL1/2, GZMH, GZMA, GZMB, PRF1, NKG7, CRTAM are classic NK cell markers. * **CD8+ T cells:** CD8A, CD8B, GZMA, GZMB, GZMK, PRF1, NKG7, IFNG, CCL4/5 are hallmark markers of cytotoxic CD8+ T cells. * **γδ T cells:** TRGC1, TRGC2 are definitive markers for γδ T cells, which can also exhibit cytotoxic functions. * **Shared Cytotoxic Program:** The high expression of granzymes (GZMA, GZMB, GZMH, GZMK), perforin (PRF1), and NKG7 indicates a strong cytotoxic effector phenotype, common to both NK cells and activated cytotoxic T cells. **Step 4: Determine the Most Probable General Cell Type** Based on the overwhelming presence of cytotoxic granule components (granzymes, perforin, NKG7), NK cell receptors (KLRC2, KLRK1, KLRD1), and T cell co-receptors (CD8A, CD8B, TRGC1/2), the most probable general cell type is **Cytotoxic Lymphocytes**. **Step 5: Identify the Top 3 Most Probable Sub Cell Types** 1. **Most Likely: Activated Cytotoxic T Cells (CD8+ T cells and/or γδ T cells) with NK-like features.** * **Reasoning:** The co-expression of CD8A/B (classic CD8+ T cell markers) with TRGC1/2 (γδ T cell markers) strongly points to cytotoxic T cells. The presence of a full suite of granzymes (GZMA, GZMB, GZMH, GZMK) and PRF1, along with IFNG, CCL4/5, and co-stimulatory/inhibitory molecules like TNFRSF9, TIGIT, and LAG3, indicates a highly activated and effector-like state. The expression of some NK cell-associated receptors like KLRK1 (NKG2D) and CD160 is also observed on activated cytotoxic T cells, particularly those with an effector memory or tissue-resident memory phenotype, or even MAIT cells (which can express some NK receptors). The presence of CRTAM further supports this, as it's found on both NK and activated T cells. The high expression of XCL1/2 is also characteristic of activated cytotoxic T cells. 2. **Second Most Likely: Natural Killer (NK) Cells.** * **Reasoning:** The strong expression of multiple NK-specific C-type lectin receptors (KLRC2, KLRK1, KLRC4, KLRD1), along with CD160, CRTAM, and the full cytotoxic machinery (granzymes, perforin, NKG7, XCL1/2, CCL4/5, IFNG), makes NK cells a very strong candidate. However, the definitive presence of CD8A/B and TRGC1/2 pushes them slightly below activated T cells in this specific ranking, as NK cells typically lack TCRs and CD8. It's possible this cluster represents a mixed population or NK cells with some shared cytotoxic gene expression. 3. **Third Most Likely: NKT-like Cells or Innate Lymphoid Cells (ILC1).** * **Reasoning:** NKT cells share features of both T cells and NK cells, expressing a TCR (often invariant) and NK cell markers. ILC1s are a subset of ILCs that resemble NK cells in their cytotoxic function and cytokine production (e.g., IFNG) but lack TCRs. The mixed expression profile, particularly the presence of both T cell and NK cell markers, could indicate such a population. However, without specific invariant TCR alpha chains (for NKT) or more definitive ILC markers, it's harder to pinpoint precisely. The strong cytotoxic program aligns well with ILC1s. **Most Likely Subtype:** Given the definitive presence of **CD8A, CD8B, TRGC1, and TRGC2** alongside the robust cytotoxic machinery and NK-associated receptors (like KLRK1/NKG2D which can be expressed on activated CD8+ T cells), the most likely subtype is **Activated Cytotoxic T Lymphocytes, specifically a population enriched for CD8+ T cells and/or γδ T cells, exhibiting a strong effector/cytotoxic phenotype and potentially some NK-like receptor expression.** This could represent tissue-resident memory T cells (TRM) or highly activated effector T cells in the large intestine. **Step 6: Provide a Concise Summary of Your Analysis** This cell cluster from the large intestine exhibits a highly activated and cytotoxic phenotype. The strong co-expression of definitive T cell markers (CD8A, CD8B, TRGC1, TRGC2) with a comprehensive suite of cytotoxic effector molecules (GZMA, GZMB, GZMH, GZMK, PRF1, NKG7), chemokines (XCL1, XCL2, CCL4, CCL5), and immunomodulatory cytokines (IFNG) is characteristic of effector cytotoxic T lymphocytes. The presence of NK-associated receptors such as KLRK1 (NKG2D), KLRC2 (NKG2C), KLRD1 (CD94), and CD160 further suggests a highly activated state, potentially representing T cells that have acquired NK-like features or a population with shared cytotoxic programs. Inhibitory receptors like TIGIT and LAG3, along with co-stimulatory TNFRSF9, indicate an active immune response and potential for immune regulation. Therefore, the cluster is most consistent with **Activated Cytotoxic T Lymphocytes, likely comprising CD8+ T cells and/or γδ T cells, with a pronounced effector phenotype.** FINAL ANNOTATION COMPLETED | Coupling Validator: Validation result: VALIDATION PASSED | Formatting Agent: ```json { ""main_cell_type"": ""Cytotoxic Lymphocytes"", ""sub_cell_types"": [ ""Activated Cytotoxic T Cells (CD8+ T cells and/or \u03b3\u03b4 T cells) with NK-like features"", ""Natural Killer (NK) Cells"", ""NKT-like Cells or Innate Lymphoid Cells (ILC1)"" ], ""possible_mixed_cell_types"": [ ""Activated Cytotoxic T Lymphocytes, specifically a population enriched for CD8+ T cells and/or \u03b3\u03b4 T cells, exhibiting a strong effector/cytotoxic phenotype and potentially some NK-like receptor expression."" ] } ```"
intestinal crypt stem cell,Intestinal Stem Cell (ISC),"Lgr5+ Intestinal Stem Cells (Active/Cycling), Early Progenitor Cells (Transit-Amplifying Cells), Secretory Progenitor Cells (e.g., early Paneth or Goblet cell progenitors)",,50,"AL031284.1, AC012085.1, IGFBPL1, HMGN2P6, CHCHD2P9, PPIAP40, LGR5, RPL7P54, AC010132.3, EIF5AP4, AC008694.2, COX5AP2, TDGF1, ASCL2, AC092670.1, NPM1P6, PPIAP11, AC090498.1, RPL41P1, CYCSP55, HMGN2P4, TPI1P1, RPL41P5, AL162151.2, PPIAP29, HNRNPA1P4, AC016596.2, AL603825.1, RPL9P21, AC005884.2, PPIAP31, HMGN1P36, HMGN2P41, AL035411.1, RPS26P39, FABP5P7, SDHDP6, ATP5PFP1, EEF1A1P5, RPSAP8, HMGN2P3, SLC39A2, KRT8P13, RPL21P16, RPSAP15, HMGN1P38, AF279873.1, RPL7P6, AC112491.1, AC022968.1",1,google/gemini-2.5-flash,openrouter,large intestine,human,N/A,"Final Annotation Agent: Here's a detailed analysis of the provided marker list for single-cell annotation: **Step 1. List the Key Functional Markers:** Many of the listed genes are pseudogenes (indicated by 'P' in their names, e.g., HMGN2P6, RPL7P54, PPIAP40, etc.) or uncharacterized loci (e.g., AL031284.1, AC012085.1). These are generally not considered key functional markers for cell type identification as they often lack protein-coding capacity or well-defined biological roles. However, some protein-coding genes are present: * **IGFBPL1 (Insulin-like Growth Factor Binding Protein Like 1):** While its exact function is not fully elucidated, IGFBPs are known to modulate the bioavailability and activity of IGFs, which are crucial for cell growth, proliferation, and differentiation. In some contexts, IGFBPL1 has been implicated in cell adhesion and tumor suppression. Its presence here might suggest active cellular processes related to growth or tissue maintenance. * **TDGF1 (Teratocarcinoma-Derived Growth Factor 1, also known as Cripto):** A member of the epidermal growth factor-CFC (EGF-CFC) family, TDGF1 is a co-receptor for Nodal and Activin signaling pathways, which are critical for embryonic development, stem cell maintenance, and cell fate determination. Its expression in adult tissues is often associated with stem cell populations or progenitor cells, particularly in the gut. * **ASCL2 (Achaete-scute homolog 2):** A basic helix-loop-helix (bHLH) transcription factor, ASCL2 is a well-established and critical regulator of intestinal stem cell (ISC) identity and self-renewal. It is essential for maintaining the Lgr5+ stem cell population in the intestinal crypts. * **SLC39A2 (Solute Carrier Family 39 Member 2, also known as ZIP2):** This gene encodes a zinc transporter. Zinc is an essential trace element involved in numerous cellular processes, including enzyme activity, gene expression, and immune function. Its specific role in this context might relate to the metabolic demands or specific functions of the cell type. **Step 2. List the Key Cell Type Markers:** * **LGR5 (Leucine-rich repeat-containing G protein-coupled receptor 5):** This is the most prominent and widely recognized marker in the list. LGR5 is a canonical marker for actively cycling intestinal stem cells (ISCs) located at the bottom of the crypts of Lieberkühn in the small intestine and colon. These cells are responsible for regenerating the entire intestinal epithelium. Its high expression is a strong indicator of an ISC population. * **ASCL2:** As mentioned above, ASCL2 is not only a functional regulator but also a key marker for Lgr5+ intestinal stem cells, working in concert with LGR5 to maintain stemness. **Step 3. Cross-reference Known Databases:** * **LGR5:** Extensive literature and scRNA-seq databases (e.g., Human Cell Atlas, specific gut scRNA-seq datasets) consistently identify LGR5 as the definitive marker for intestinal stem cells. Its expression is highly restricted to these cells within the intestinal epithelium. * **ASCL2:** Similarly, ASCL2 is consistently found to be co-expressed with LGR5 in intestinal stem cells. Studies have shown that ASCL2 is a direct transcriptional target of Wnt signaling, which is crucial for ISC maintenance, and it directly regulates LGR5 expression. * **TDGF1:** While not as exclusive as LGR5, TDGF1 has been reported in various stem cell populations, including embryonic stem cells and some adult stem cells. Its presence in the gut context, alongside LGR5 and ASCL2, further supports a stem/progenitor cell identity. * **IGFBPL1:** Less specific, but some studies have linked IGFBPL1 to cancer stem cells or progenitor populations in other tissues. Its role in normal intestinal stem cells is less defined but could be related to growth factor signaling in the niche. * **SLC39A2:** While zinc transporters are ubiquitous, specific zinc transporters can be enriched in certain cell types based on their metabolic needs. Its presence here might reflect the unique metabolic demands of highly proliferative stem cells. The abundance of pseudogenes and uncharacterized loci (e.g., AL031284.1, AC012085.1, AC010132.3, etc.) at high expression levels is common in scRNA-seq data, especially when dealing with highly expressed genes. These can sometimes be artifacts, non-coding RNAs, or simply highly transcribed but functionally uncharacterized genomic regions. Their presence does not detract from the strong signal provided by the known markers. **Step 4. Determine the Most Probable General Cell Type:** Based on the highly specific and canonical markers **LGR5** and **ASCL2**, the most probable general cell type is **Intestinal Stem Cell (ISC)**. The presence of TDGF1 further supports a stem/progenitor cell identity. **Step 5. Identify the Top 3 Most Probable Sub Cell Types:** Given that the general cell type is already quite specific (Intestinal Stem Cell), the sub-types would typically refer to different states or locations of ISCs, or closely related progenitor cells. 1. **Most Likely: Lgr5+ Intestinal Stem Cells (Active/Cycling):** The high expression of LGR5 and ASCL2, both canonical markers for actively cycling ISCs located at the crypt base, strongly points to this specific subtype. These cells are responsible for the rapid turnover of the intestinal epithelium. The high ranking of these markers suggests a robust and active stem cell population. 2. **Second Most Likely: Early Progenitor Cells (Transit-Amplifying Cells):** While Lgr5+ ISCs are at the apex of the hierarchy, they give rise to rapidly dividing transit-amplifying (TA) cells. Some TA cells might still retain residual LGR5 or ASCL2 expression, especially early TA cells that are still close to the stem cell niche. However, their expression levels would typically be lower than in true Lgr5+ ISCs, and they would start expressing differentiation markers. Given the high ranking of LGR5 and ASCL2, this is less likely than pure Lgr5+ ISCs but represents the immediate progeny. 3. **Third Most Likely: Secretory Progenitor Cells (e.g., early Paneth or Goblet cell progenitors):** Lgr5+ ISCs are multipotent and can differentiate into all epithelial lineages, including secretory cells (Paneth, Goblet, Enteroendocrine) and absorptive enterocytes. Some studies suggest distinct progenitor populations or transient states within the Lgr5+ compartment that are biased towards certain lineages. For example, some Lgr5+ cells might show early signs of secretory differentiation while still maintaining stemness. However, without specific secretory lineage markers (e.g., MUC2 for Goblet, DEFA5 for Paneth), this is a more speculative subtype. The current markers primarily indicate stemness rather than lineage commitment. **Most Likely Subtype:** **Lgr5+ Intestinal Stem Cells (Active/Cycling)**. The strong and high-ranking expression of both LGR5 and ASCL2 is unequivocally indicative of this specific cell population. **Step 6. Provide a Concise Summary of Your Analysis:** The single-cell cluster from the human large intestine is most confidently identified as **Lgr5+ Intestinal Stem Cells (ISCs)**. This annotation is primarily driven by the high expression of **LGR5**, the definitive marker for actively cycling intestinal stem cells, and **ASCL2**, a critical transcription factor essential for ISC maintenance and LGR5 expression. The presence of **TDGF1**, a gene associated with stemness and developmental signaling, further supports this identification. While several pseudogenes and uncharacterized loci are highly expressed, their presence does not overshadow the clear signal from these canonical stem cell markers. The most probable subtype is the actively cycling Lgr5+ Intestinal Stem Cell population, responsible for epithelial regeneration in the large intestine. FINAL ANNOTATION COMPLETED | Coupling Validator: Validation result: VALIDATION PASSED | Formatting Agent: ```json { ""main_cell_type"": ""Intestinal Stem Cell (ISC)"", ""sub_cell_types"": [ ""Lgr5+ Intestinal Stem Cells (Active/Cycling)"", ""Early Progenitor Cells (Transit-Amplifying Cells)"", ""Secretory Progenitor Cells (e.g., early Paneth or Goblet cell progenitors)"" ], ""possible_mixed_cell_types"": [] } ```"
intestinal enteroendocrine cell,Enteroendocrine Cells,"L-cells, Enterochromaffin (EC) cells, S-cells",,50,"GCG, PCSK1, AC090679.1, UCN3, PYY, INSL5, CHGA, LCN15, SCG2, FEV, CPLX2, NKX2-2, AL133325.3, C1orf127, LINC01014, SCGN, SLC18A1, SCG3, SCG5, TPH1, MARCH4, INSM1, RTN1, CRYBA2, SNAP25, CHGB, CRMP1, KCNB2, RFX6, AMER3, SLC32A1, CDK5R2, AVPR1B, VWA5B2, AC022893.2, ABCC8, RIMBP2, AL161658.1, COL2A1, CELF3, SCT, RIIAD1, SSTR5-AS1, RGS4, ARX, PRPH, INA, F5, AP003062.3, SLC5A8",1,google/gemini-2.5-flash,openrouter,large intestine,human,N/A,"Final Annotation Agent: Here's a step-by-step analysis to identify the cell type based on the provided marker list: **Step 1. List the Key Functional Markers:** * **Neuroendocrine/Hormone Production & Processing:** * **GCG (Glucagon):** Encodes proglucagon, which is processed into multiple peptide hormones including glucagon, GLP-1, and GLP-2. These are crucial for glucose homeostasis and intestinal function. * **PCSK1 (Proprotein Convertase Subtilisin/Kexin Type 1):** A proprotein convertase involved in the proteolytic processing of many prohormones and proneuropeptides, including proglucagon, proinsulin, and proopiomelanocortin. Its presence strongly indicates active hormone processing. * **UCN3 (Urocortin 3):** A neuropeptide belonging to the corticotropin-releasing hormone family, involved in stress response and gut motility regulation. * **PYY (Peptide YY):** A gut hormone released post-prandially, involved in satiety and gut motility regulation. * **INSL5 (Insulin-like Peptide 5):** A relaxin family peptide hormone, primarily expressed in enteroendocrine cells of the colon, involved in gut motility and energy homeostasis. * **CHGA (Chromogranin A):** A general marker for neuroendocrine cells, involved in the packaging and secretion of peptide hormones and neuropeptides. * **SCG2 (Secretogranin II):** Another chromogranin family member, involved in the storage and secretion of peptide hormones and neuropeptides. * **SCGN (Secretagogin):** A calcium-binding protein expressed in neuroendocrine cells, potentially involved in hormone secretion. * **SLC18A1 (VMAT1 - Vesicular Monoamine Transporter 1):** Transports monoamines (like serotonin) into synaptic vesicles, characteristic of neuroendocrine cells. * **SCG3 (Secretogranin III):** Similar to SCG2, involved in neuroendocrine granule formation. * **SCG5 (Secretogranin V / NESP55):** Another neuroendocrine secretory granule protein. * **TPH1 (Tryptophan Hydroxylase 1):** Rate-limiting enzyme in serotonin synthesis, indicating serotonin-producing cells. * **INSM1 (Insulinoma-associated protein 1):** A transcription factor crucial for neuroendocrine cell differentiation and development. * **SNAP25 (Synaptosomal-associated protein 25):** A component of the SNARE complex involved in vesicle fusion and neurotransmitter/hormone release. * **CHGB (Chromogranin B):** Another general neuroendocrine marker, similar to CHGA. * **SLC32A1 (VGAT - Vesicular GABA Transporter):** Transports GABA and glycine into synaptic vesicles, suggesting potential inhibitory neurotransmitter function, though less common in gut endocrine cells compared to other markers. * **ABCC8 (SUR1 - Sulfonylurea Receptor 1):** A component of ATP-sensitive potassium channels, often found in insulin-secreting cells (pancreatic beta cells) and some enteroendocrine cells, involved in stimulus-secretion coupling. * **SCT (Secretin):** A gut hormone that stimulates pancreatic bicarbonate secretion and regulates water homeostasis. * **ARX (Aristaless Related Homeobox):** A transcription factor involved in the development of various neuroendocrine cell types, including pancreatic alpha cells and some enteroendocrine cells. * **Neuronal/Synaptic Function (often co-expressed in neuroendocrine cells):** * **FEV (FEV Transcription Factor, ETS Family Member):** A transcription factor involved in the differentiation of specific neuroendocrine cell types, including serotonin-producing cells. * **CPLX2 (Complexin 2):** A synaptic protein involved in regulating neurotransmitter release. * **NKX2-2 (NK2 Homeobox 2):** A transcription factor important for the development of various neuroendocrine cells, including pancreatic beta and alpha cells, and some enteroendocrine cells. * **RTN1 (Reticulon 1):** Involved in ER structure and membrane trafficking, often expressed in neuronal and neuroendocrine cells. * **CRMP1 (Collapsin Response Mediator Protein 1):** Involved in neuronal development and axon guidance. * **KCNB2 (Potassium Voltage-Gated Channel Subfamily B Member 2):** A voltage-gated potassium channel, important for regulating membrane excitability. * **RFX6 (Regulatory Factor X6):** A transcription factor essential for the differentiation of multiple enteroendocrine and pancreatic islet cell types. * **RIMBP2 (RIM-Binding Protein 2):** Involved in synaptic vesicle release. * **PRPH (Peripherin):** An intermediate filament protein found in peripheral neurons and some neuroendocrine cells. * **INA (Internexin Neuronal Intermediate Filament Protein Alpha):** Another intermediate filament protein characteristic of neurons and neuroendocrine cells. * **Other/Less Specific:** * **LCN15 (Lipocalin 15):** Function less clearly defined in this context, but lipocalins can be involved in various transport and signaling roles. * **MARCH4 (Membrane Associated Ring-CH-Type Finger 4):** An E3 ubiquitin ligase, generally involved in protein degradation. * **CRYBA2 (Crystallin Beta A2):** Typically found in the lens of the eye, its expression here might be off-target or indicate a less common function. * **CDK5R2 (Cyclin Dependent Kinase 5 Regulatory Subunit Associated Protein 2):** Involved in neuronal development and function. * **AVPR1B (Arginine Vasopressin Receptor 1B):** A G-protein coupled receptor for vasopressin, involved in stress response and hormone regulation. * **CELF3 (CUGBP Elav-Like Family Member 3):** An RNA binding protein, involved in RNA processing. * **RGS4 (Regulator of G Protein Signaling 4):** Modulates G-protein coupled receptor signaling. * **SLC5A8 (Sodium-coupled monocarboxylate transporter 1):** Involved in the transport of short-chain fatty acids and other monocarboxylates. **Step 2. List the Key Cell Type Markers:** The overwhelming majority of the highly expressed markers point towards a **neuroendocrine cell lineage**, specifically within the gastrointestinal tract. * **General Neuroendocrine Markers:** CHGA, CHGB, SCG2, SCGN, SCG3, SCG5, INSM1, SNAP25, PRPH, INA. * **Enteroendocrine Hormone/Peptide Markers:** GCG (proglucagon products like GLP-1, GLP-2), PYY, INSL5, UCN3, SCT. * **Hormone Processing/Secretion Machinery:** PCSK1, SLC18A1, ABCC8. * **Transcription Factors for Enteroendocrine Development:** FEV, NKX2-2, RFX6, ARX. * **Serotonin Synthesis:** TPH1. **Step 3. Cross-reference Known Databases:** A quick search of these markers (e.g., GCG, PYY, INSL5, UCN3, CHGA, PCSK1, TPH1, FEV, RFX6, NKX2-2) in scRNA-seq databases and literature for the large intestine consistently points to **enteroendocrine cells**. * **GCG, PYY, INSL5, UCN3, SCT:** These are classic hormones produced by various enteroendocrine cell subtypes in the gut. * **PCSK1:** Essential for processing these prohormones. * **CHGA, CHGB, SCG family:** Universal neuroendocrine markers. * **TPH1, FEV:** Strongly associated with enterochromaffin (EC) cells, which produce serotonin. * **RFX6, NKX2-2, INSM1, ARX:** Key transcription factors driving enteroendocrine cell differentiation. **Step 4. Determine the Most Probable General Cell Type:** Based on the extensive list of neuroendocrine markers, hormone production machinery, and specific gut hormone genes, the most probable general cell type is **Enteroendocrine Cells**. **Step 5. Identify the Top 3 Most Probable Sub Cell Types:** Enteroendocrine cells are a heterogeneous population, each subtype producing a specific set of hormones. 1. **Most Likely: L-cells (or GLP-1/PYY/GCG-producing cells):** * **Strong evidence:** High expression of **GCG**, **PYY**, and **INSL5**. L-cells are the primary source of GLP-1, GLP-2 (both derived from proglucagon, GCG), and PYY in the large intestine. INSL5 is also a characteristic marker of colonic L-cells. * **Supporting markers:** PCSK1 (for processing proglucagon and proPYY), CHGA, CHGB, SCG family (general neuroendocrine markers), RFX6, NKX2-2 (transcription factors involved in L-cell development). * **Rationale:** The co-expression and high ranking of GCG, PYY, and INSL5 are highly specific to L-cells, especially in the large intestine. 2. **Second Most Likely: Enterochromaffin (EC) cells:** * **Strong evidence:** High expression of **TPH1** and **FEV**. TPH1 is the rate-limiting enzyme for serotonin synthesis, and FEV is a key transcription factor for EC cell differentiation. * **Supporting markers:** SLC18A1 (VMAT1, for packaging serotonin), CHGA, CHGB, SCG family (general neuroendocrine markers), INSM1. * **Rationale:** While not as prominent as the L-cell markers, TPH1 and FEV are strong indicators of serotonin-producing EC cells. EC cells are the most abundant enteroendocrine cell type in the gut. 3. **Third Most Likely: S-cells (Secretin-producing cells):** * **Strong evidence:** Expression of **SCT (Secretin)**. * **Supporting markers:** PCSK1, CHGA, CHGB, SCG family (general neuroendocrine markers), RFX6, INSM1. * **Rationale:** The presence of SCT directly points to S-cells. While S-cells are more abundant in the duodenum, they are present throughout the small and large intestine. The ranking of SCT is lower than GCG/PYY/INSL5, suggesting they might be a smaller population or less highly expressed in this specific cluster compared to L-cell markers. **Most Likely Subtype:** Based on the highest ranked and most specific markers (GCG, PYY, INSL5), the most likely subtype is **L-cells**. **Step 6. Provide a Concise Summary of Your Analysis:** The single-cell cluster from the large intestine exhibits a robust and highly specific expression profile indicative of **enteroendocrine cells**. Key functional markers such as **GCG, PYY, INSL5, UCN3, and SCT** confirm the production of various gut hormones. The presence of **PCSK1** highlights active prohormone processing, while general neuroendocrine markers like **CHGA, CHGB, and the SCG family** further support this classification. Transcription factors critical for neuroendocrine development, including **INSM1, FEV, NKX2-2, RFX6, and ARX**, are also highly expressed. Based on the specific combination and high expression of **GCG, PYY, and INSL5**, the most probable subtype is **L-cells**, which are known to produce GLP-1, GLP-2, PYY, and INSL5, particularly in the colon. The presence of **TPH1 and FEV** suggests a contribution from Enterochromaffin (EC) cells, and **SCT** indicates the presence of S-cells, but these appear to be less dominant in this specific cluster compared to the L-cell signature. **FINAL ANNOTATION COMPLETED** | Coupling Validator: Validation result: VALIDATION PASSED | Formatting Agent: ```json { ""main_cell_type"": ""Enteroendocrine Cells"", ""sub_cell_types"": [""L-cells"", ""Enterochromaffin (EC) cells"", ""S-cells""], ""possible_mixed_cell_types"": [] } ```"
monocyte,Neural/Glial Cells of the Enteric Nervous System,"Schwann Cells (Myelinating or Non-myelinating), Enteric Glial Cells (EGCs), Enteric Neurons (Developing or Specific Subtypes)","The strong presence of neuronal functional markers (e.g., NRXN1, SYT10, GRIK3) suggests either a highly interactive glial cell type or a population that includes some neuronal components, or perhaps a progenitor state with neuronal potential.",50,"NKAIN3, SPP1, CDH19, TSPAN11, PLP1, L1CAM, MYOT, IGSF11, NRXN1, SLC35F1, AL136298.1, SFRP5, Z97205.2, AL358216.1, SOX10, MEGF10, SYT10, CADM2, SLITRK2, SOX2, CRTAC1, CHL1, ZNF536, FOXD3, PTPRZ1, GRIK3, TUBB2B, CMTM5, LINC01436, TTYH1, ADARB2, CDH2, TENM3, WNT6, ATP1A2, NRXN3, KCNMB4, TMEM132B, LPL, GFRA2, CHADL, FLRT1, CHST9, GJC3, Z95114.1, RHAG, FOXD3-AS1, BMS1P10, FAM19A5, FGFBP2",1,google/gemini-2.5-flash,openrouter,large intestine,human,N/A,"Final Annotation Agent: Okay, I'm ready to analyze this list of highly expressed markers from a single-cell cluster in human large intestine tissue. I will follow the steps outlined to provide a comprehensive and specific cell type annotation. **Input Marker List (ranked by expression intensity, high to low):** NKAIN3, SPP1, CDH19, TSPAN11, PLP1, L1CAM, MYOT, IGSF11, NRXN1, SLC35F1, AL136298.1, SFRP5, Z97205.2, AL358216.1, SOX10, MEGF10, SYT10, CADM2, SLITRK2, SOX2, CRTAC1, CHL1, ZNF536, FOXD3, PTPRZ1, GRIK3, TUBB2B, CMTM5, LINC01436, TTYH1, ADARB2, CDH2, TENM3, WNT6, ATP1A2, NRXN3, KCNMB4, TMEM132B, LPL, GFRA2, CHADL, FLRT1, CHST9, GJC3, Z95114.1, RHAG, FOXD3-AS1, BMS1P10, FAM19A5, FGFBP2 --- **1. List the Key Functional Markers:** This list contains a significant number of genes associated with neuronal development, function, and cell adhesion. * **NKAIN3 (Na+/K+ transporting ATPase interacting 3):** Involved in neuronal differentiation and axon guidance. * **SPP1 (Secreted Phosphoprotein 1, Osteopontin):** While often associated with immune responses and bone, it can also be expressed in neural tissues and involved in cell adhesion and migration. Its high expression here warrants attention. * **PLP1 (Proteolipid Protein 1):** A major component of myelin in the central and peripheral nervous systems. Its presence is a strong indicator of myelinating cells. * **L1CAM (L1 Cell Adhesion Molecule):** A crucial cell adhesion molecule involved in neuron migration, axon guidance, and fasciculation. Highly expressed in developing and mature neurons. * **NRXN1 (Neurexin 1):** A presynaptic cell adhesion molecule critical for synapse formation and function. * **IGSF11 (Immunoglobulin Superfamily Member 11):** Involved in cell adhesion, particularly in neural tissues. * **SYT10 (Synaptotagmin 10):** A member of the synaptotagmin family, involved in calcium-dependent membrane trafficking and neurotransmitter release, typically found in neurons. * **CADM2 (Cell Adhesion Molecule 2):** Involved in cell adhesion and synapse formation. * **SLITRK2 (SLIT and NTRK Like Family Member 2):** Involved in neuronal development and synapse formation. * **CHL1 (Cell Adhesion Molecule L1 Like):** Another L1CAM family member, involved in neuronal migration and axon guidance. * **PTPRZ1 (Protein Tyrosine Phosphatase Receptor Type Z1):** A receptor-type protein tyrosine phosphatase expressed in the central nervous system, involved in neural development and synaptic plasticity. * **GRIK3 (Glutamate Ionotropic Receptor Kainate Type Subunit 3):** A subunit of kainate receptors, which are ionotropic glutamate receptors mediating excitatory neurotransmission. Strong neuronal marker. * **TUBB2B (Tubulin Beta 2B Class IIb):** A beta-tubulin isoform predominantly expressed in neurons, involved in microtubule formation and neuronal migration. * **TTYH1 (Tweety Homolog 1):** A calcium-activated chloride channel, expressed in neurons and involved in neuronal excitability. * **ADARB2 (Adenosine Deaminase RNA Specific B2):** Involved in RNA editing, particularly in the nervous system. * **CDH2 (Cadherin 2, N-cadherin):** A classical cadherin involved in cell-cell adhesion, crucial for neural development and synapse formation. * **TENM3 (Teneurin Transmembrane Protein 3):** Involved in neural circuit assembly and synapse formation. * **ATP1A2 (ATPase Na+/K+ Transporting Subunit Alpha 2):** A subunit of the Na+/K+-ATPase, critical for maintaining ion gradients and neuronal excitability. * **NRXN3 (Neurexin 3):** Another neurexin family member, involved in synapse formation. * **GFRA2 (GDNF Family Receptor Alpha 2):** A receptor for glial cell line-derived neurotrophic factor (GDNF) family ligands, important for neuronal survival and differentiation. * **FLRT1 (Fibronectin Leucine Rich Transmembrane Protein 1):** Involved in cell adhesion and neural development. **Summary of Functional Markers:** The overwhelming majority of the top markers are directly involved in neuronal structure, function, adhesion, and development, including synapse formation, axon guidance, and myelination. This strongly points towards a neural cell type. --- **2. List the Key Cell Type Markers:** Based on the functional markers, I will now look for specific cell type markers within the neural lineage. * **PLP1 (Proteolipid Protein 1):** As mentioned, a primary component of myelin. In the peripheral nervous system (PNS), this is a hallmark of Schwann cells. In the central nervous system (CNS), it's a hallmark of oligodendrocytes. Given the large intestine context, Schwann cells are more likely. * **SOX10 (SRY-Box Transcription Factor 10):** A crucial transcription factor for neural crest development, essential for the differentiation and maintenance of Schwann cells, melanocytes, and enteric neurons. Its presence is a very strong indicator of neural crest-derived cells, particularly Schwann cells in the PNS. * **L1CAM (L1 Cell Adhesion Molecule):** Expressed by neurons and Schwann cells. * **CDH19 (Cadherin 19):** While less specific, it has been reported in some neural crest-derived cells and some epithelial cells. Its co-expression with strong neural markers suggests a neural context here. * **MYOT (Myotilin):** Primarily known for its role in muscle, but also reported in some neural contexts, though less specific than others. Its high ranking here is somewhat unusual for a pure neural cell and might suggest a specific subtype or a less common expression pattern. * **SOX2 (SRY-Box Transcription Factor 2):** A pluripotency factor, but also expressed in neural stem cells, radial glia, and some mature neural cells, including enteric neurons and glia. Its co-expression with SOX10 is significant. * **FOXD3 (Forkhead Box D3):** A transcription factor critical for neural crest development and maintenance. Its presence further supports a neural crest origin. * **CRTAC1 (Cartilage Associated Protein 1):** While its name suggests cartilage, it has been found expressed in some neural populations and involved in cell adhesion. * **CMTM5 (Chemokine Like Receptor 5):** Less specific, but has been implicated in various cell types, including some neural contexts. * **LPL (Lipoprotein Lipase):** Involved in lipid metabolism. While not a primary neural marker, Schwann cells are highly metabolically active and involved in lipid synthesis for myelin. * **CHADL (Chondroadherin Like):** Similar to CRTAC1, its name suggests cartilage, but its expression in neural contexts, though less common, is possible. **Summary of Cell Type Markers:** The combination of **PLP1, SOX10, L1CAM, SOX2, and FOXD3** is highly indicative of neural crest-derived cells, specifically pointing towards Schwann cells or enteric glial cells, which are both found in the large intestine and are responsible for myelination and support of enteric neurons. The presence of PLP1 is a strong differentiator for myelinating cells. --- **3. Cross-reference Known Databases:** I will cross-reference these markers with common scRNA-seq databases (e.g., Human Cell Atlas, PanglaoDB, CellMarker, literature on gut scRNA-seq). * **PLP1:** Consistently found as a marker for Schwann cells and oligodendrocytes. In the large intestine, this points to Schwann cells. * **SOX10:** A definitive marker for neural crest derivatives, including Schwann cells, enteric glia, and melanocytes. In the gut, it's key for Schwann cells and enteric glia. * **L1CAM:** Expressed by neurons and Schwann cells. * **NRXN1, SYT10, GRIK3, TUBB2B, CDH2, TENM3, ATP1A2, NRXN3:** These are strong neuronal and synaptic markers. Their presence alongside PLP1 and SOX10 suggests a close association or co-expression in a neural support cell type that interacts heavily with neurons, or perhaps a mixed population, but the high ranking of PLP1 and SOX10 suggests a glial component. * **FOXD3, SOX2:** Markers for neural stem/progenitor cells and neural crest derivatives. * **SPP1:** While often immune, it's also reported in some neural contexts, including Schwann cells under certain conditions (e.g., injury, regeneration). * **MYOT:** Less common in neural cells, but some studies have reported its expression in specific neuronal or glial subtypes. Its high expression here is notable. **Database Cross-referencing Conclusion:** The marker profile is highly consistent with neural crest-derived cells, specifically Schwann cells or enteric glial cells, which are the primary myelinating and supportive glial cells in the peripheral nervous system, including the enteric nervous system of the large intestine. The strong presence of neuronal functional markers (e.g., NRXN1, SYT10, GRIK3) suggests either a highly interactive glial cell type or a population that includes some neuronal components, or perhaps a progenitor state with neuronal potential. However, the definitive glial markers (PLP1, SOX10) are very high. --- **4. Determine the Most Probable General Cell Type:** Based on the strong and consistent expression of **PLP1, SOX10, L1CAM, NRXN1, SYT10, FOXD3, and SOX2**, the most probable general cell type is **Neural/Glial Cells of the Enteric Nervous System (ENS)**. These are cells derived from the neural crest, forming the intrinsic nervous system of the gut. --- **5. Identify the Top 3 Most Probable Sub Cell Types:** Given the context of the large intestine and the specific markers: 1. **Schwann Cells (Myelinating or Non-myelinating):** * **Reasoning:** The presence of **PLP1** is a very strong indicator of myelinating cells. **SOX10** is a master regulator of Schwann cell development and maintenance. **L1CAM, NRXN1, CDH2, TENM3** are all involved in axon-Schwann cell interactions and myelination. Schwann cells are the primary glial cells of the peripheral nervous system (which includes the ENS) responsible for myelination and support of axons. Non-myelinating Schwann cells also express SOX10 and interact closely with axons. The high expression of neuronal functional markers (e.g., NRXN1, SYT10) is consistent with Schwann cells closely interacting with and supporting neurons. SPP1 has also been reported in Schwann cells, particularly in response to injury or during development. 2. **Enteric Glial Cells (EGCs):** * **Reasoning:** EGCs are a diverse population of neural crest-derived cells within the ENS. They share many markers with Schwann cells, including **SOX10, L1CAM, SOX2, and FOXD3**. While not all EGCs are myelinating (and thus might not express high PLP1), some EGC subtypes have been shown to express PLP1 or have myelin-like functions. EGCs play crucial roles in maintaining gut homeostasis, supporting enteric neurons, and modulating immune responses. The presence of SPP1 could also align with EGCs involved in immune modulation. 3. **Enteric Neurons (Developing or Specific Subtypes):** * **Reasoning:** Many markers in the list are definitive neuronal markers (e.g., **NRXN1, SYT10, GRIK3, TUBB2B, TTYH1, ATP1A2, NRXN3**). The co-expression of these with strong glial markers (PLP1, SOX10) is intriguing. It could represent a mixed cluster, or a population of developing neurons that still express some progenitor/glial-like markers, or a specific neuronal subtype that has unique expression patterns. However, the very high ranking of PLP1 and SOX10 makes a purely neuronal annotation less likely as the primary identity. If it were purely neuronal, we would expect more classical pan-neuronal markers (e.g., TUBB3, MAP2, SYP) to be higher, and PLP1 to be absent or very low. The presence of SOX2 and FOXD3 also points to a less mature or progenitor state, or a neural crest derivative. **Most Likely Subtype:** Based on the very high expression of **PLP1** and **SOX10**, the most likely subtype is **Schwann Cells (likely myelinating, or a population with myelinating potential/characteristics)**. The strong presence of neuronal interaction markers further supports their role as supportive cells for axons within the ENS. While EGCs are very similar, the definitive myelin component (PLP1) pushes it more towards Schwann cells, which are the primary myelin-forming cells in the PNS/ENS. --- **6. Provide a Concise Summary of Your Analysis:** This cell cluster from the human large intestine exhibits a highly characteristic gene expression profile indicative of neural crest-derived cells, specifically those involved in the enteric nervous system. The most prominent markers, **PLP1 (Proteolipid Protein 1)** and **SOX10 (SRY-Box Transcription Factor 10)**, are definitive for myelinating glial cells and neural crest derivatives, respectively. The co-expression of numerous neuronal adhesion and synaptic function genes (e.g., L1CAM, NRXN1, SYT10, GRIK3, CDH2, TENM3) strongly suggests a cell type that intimately interacts with and supports axons. Other neural crest and progenitor markers like SOX2 and FOXD3 further support this lineage. Considering the tissue context (large intestine) and the specific marker combination, the most probable general cell type is **Neural/Glial Cells of the Enteric Nervous System**. Among the specific subtypes, **Schwann Cells** are the most likely candidate, particularly those with myelinating characteristics, given the high expression of PLP1. Enteric Glial Cells are a close second, sharing many features with Schwann cells. While neuronal markers are present, their co-occurrence with strong glial markers suggests a supportive glial role rather than a purely neuronal identity. **FINAL ANNOTATION COMPLETED** | Coupling Validator: Validation result: VALIDATION PASSED | Formatting Agent: ```json { ""main_cell_type"": ""Neural/Glial Cells of the Enteric Nervous System"", ""sub_cell_types"": [ ""Schwann Cells (Myelinating or Non-myelinating)"", ""Enteric Glial Cells (EGCs)"", ""Enteric Neurons (Developing or Specific Subtypes)"" ], ""possible_mixed_cell_types"": [ ""The strong presence of neuronal functional markers (e.g., NRXN1, SYT10, GRIK3) suggests either a highly interactive glial cell type or a population that includes some neuronal components, or perhaps a progenitor state with neuronal potential."" ] } ```"
plasma cell,Plasma Cell,"IgA-secreting Plasma Cells, IgG-secreting Plasma Cells, IgM-secreting Plasma Cells",,50,"IGLL5, IGLV6-57, JCHAIN, FAM92B, IGLC3, IGLC2, IGHV3-7, IGKC, TNFRSF17, IGHG1, AC026369.3, IGHV3-23, IGKV4-1, IGKV1-5, IGHA1, IGLV3-1, IGLV2-11, MYL2, MZB1, IGHG3, IGHV3-74, IGHM, ANKRD36BP2, AMPD1, IGKV3-20, IGHA2, DERL3, AC104699.1, LINC02362, AL391056.1, LILRB4, CCL3, BMP6, UBE2QL1, LINC00309, AL133467.1, GPRC5D, FCRL5, DNAAF1, AP002852.1, AC007569.1, CXorf21, RNU1-85P, U62317.4, TXNDC5, LINC02384, CCR10, BFSP2, APOBEC3A, AC106897.1",1,google/gemini-2.5-flash,openrouter,large intestine,human,N/A,"Final Annotation Agent: Here's a detailed analysis to identify the cell type based on the provided marker list: ## Step-by-Step Cell Type Annotation ### 1. List the Key Functional Markers The most prominent functional markers in this list are overwhelmingly related to immunoglobulin production and secretion. * **Immunoglobulin Light Chain Genes:** * **IGLL5, IGLV6-57, IGLC3, IGLC2, IGKC, IGKV4-1, IGKV1-5, IGLV3-1, IGLV2-11, IGKV3-20:** These genes encode various components of the immunoglobulin light chain (lambda and kappa). Their high expression indicates active synthesis of light chains, a hallmark of antibody-producing cells. IGLL5, in particular, is often associated with plasma cells and B cell differentiation. * **Immunoglobulin Heavy Chain Genes:** * **IGHV3-7, IGHG1, IGHV3-23, IGHA1, IGHG3, IGHM, IGHV3-74, IGHA2:** These genes encode different classes and variable regions of the immunoglobulin heavy chain (IgG1, IgA1, IgG3, IgM). The presence of multiple heavy chain isotypes (IgG, IgA, IgM) suggests a mature B-cell lineage capable of class-switching, a characteristic feature of plasma cells. * **JCHAIN (Joining Chain):** This gene encodes the J chain, a small polypeptide that links monomeric immunoglobulin units (IgM and IgA) into polymeric forms (pentameric IgM and dimeric IgA), which are then secreted. Its high expression is a strong indicator of active antibody secretion. * **TNFRSF17 (BCMA - B-cell maturation antigen):** A receptor expressed on mature B cells and plasma cells. It plays a crucial role in B cell survival and differentiation into plasma cells. High expression is a strong indicator of plasma cell identity. * **MZB1 (Marginal Zone B and B1 cell specific protein 1):** While initially identified in marginal zone B cells, MZB1 is also highly expressed in plasma cells, where it plays a role in immunoglobulin assembly and secretion. * **DERL3 (Derlin 3):** Involved in endoplasmic reticulum-associated degradation (ERAD), a pathway crucial for protein quality control. Plasma cells have a highly developed ER and are under significant ER stress due to massive antibody production, making DERL3 expression relevant. * **GPRC5D (G protein-coupled receptor class C group 5 member D):** While its exact role in plasma cells is still being elucidated, it is known to be expressed on plasma cells and is a target for multiple myeloma therapies. * **FCRL5 (Fc receptor-like 5):** Expressed on a subset of B cells and plasma cells, it can modulate B cell receptor signaling. ### 2. List the Key Cell Type Markers Based on the functional markers, the key cell type markers are predominantly indicative of the **plasma cell lineage**. * **IGLL5, JCHAIN, TNFRSF17, MZB1, IGHG1, IGHA1, IGHM, IGLC3, IGLC2, IGKC, IGHV3-7, IGHV3-23, IGKV4-1, IGKV1-5, IGLV3-1, IGLV2-11, IGHG3, IGHV3-74, IGKV3-20, IGHA2:** All these genes, as detailed above, are directly involved in immunoglobulin synthesis, assembly, and secretion, which are the defining functions of plasma cells. The presence of multiple heavy and light chain genes, along with JCHAIN, strongly points to a cell actively producing and secreting antibodies. TNFRSF17 (BCMA) is a canonical plasma cell marker. MZB1 is also highly enriched in plasma cells. * **LILRB4 (Leukocyte immunoglobulin-like receptor subfamily B member 4):** Also known as ILT3, this is an inhibitory receptor expressed on myeloid cells, but also on some B cells and plasma cells, particularly in certain inflammatory contexts. Its presence here might suggest a specific activation state or microenvironment. * **CCL3 (Chemokine (C-C motif) ligand 3):** A chemokine that can be produced by various immune cells, including activated B cells and plasma cells, to recruit other immune cells. * **APOBEC3A (Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A):** While known for its role in innate immunity against viruses, it has also been implicated in B cell somatic hypermutation and class switch recombination, processes that precede and occur during plasma cell differentiation. ### 3. Cross-reference Known Databases Cross-referencing these markers with scRNA-seq databases (e.g., Human Cell Atlas, PanglaoDB, CellMarker, ImmGen) and literature consistently identifies this gene signature with **plasma cells**. * **IGLL5, JCHAIN, TNFRSF17, MZB1, IGHG1, IGHA1, IGHM, IGLC3, IGKC:** These are universally recognized as top markers for plasma cells across various tissues, including the large intestine. The co-expression of multiple immunoglobulin heavy and light chain genes, especially with JCHAIN and TNFRSF17, is highly specific to antibody-secreting plasma cells. * The presence of both IgG (IGHG1, IGHG3) and IgA (IGHA1, IGHA2) heavy chains is particularly relevant for mucosal tissues like the large intestine, where IgA-secreting plasma cells are abundant. ### 4. Determine the Most Probable General Cell Type Based on the overwhelming evidence from the key functional and cell type markers, the most probable general cell type is **Plasma Cell**. The gene list is dominated by immunoglobulin genes (heavy and light chains of various isotypes), JCHAIN (for polymerization and secretion), and specific plasma cell markers like TNFRSF17 (BCMA) and MZB1. This combination is unequivocally characteristic of antibody-secreting cells. ### 5. Identify the Top 3 Most Probable Sub Cell Types Given that the general cell type is Plasma Cell, we need to consider subtypes based on their location, activation state, or specific immunoglobulin isotype production. 1. **Most Likely: IgA-secreting Plasma Cells (Mucosal Plasma Cells)** * **Reasoning:** The large intestine is a mucosal tissue. **IGHA1** and **IGHA2** are prominently expressed, indicating active production of IgA. Mucosal plasma cells, particularly in the gut, are predominantly IgA-secreting, playing a critical role in mucosal immunity. The presence of **JCHAIN** further supports the secretion of dimeric IgA. * **Supporting Markers:** IGHA1, IGHA2, JCHAIN. 2. **Second Most Likely: IgG-secreting Plasma Cells** * **Reasoning:** While IgA is dominant in the gut mucosa, IgG-secreting plasma cells are also present, contributing to systemic and local immunity. The expression of **IGHG1** and **IGHG3** indicates active IgG production. These cells might represent a subset that has undergone class switching to IgG or are derived from B cells that migrated from systemic sites. * **Supporting Markers:** IGHG1, IGHG3. 3. **Third Most Likely: IgM-secreting Plasma Cells** * **Reasoning:** IgM-secreting plasma cells are typically found earlier in immune responses or in specific anatomical locations (e.g., marginal zone). While less abundant than IgA or IgG plasma cells in the steady-state large intestine, their presence is possible, especially in response to acute stimuli. The expression of **IGHM** supports this. * **Supporting Markers:** IGHM, JCHAIN (for pentameric IgM). **Most Likely Subtype:** Based on the tissue context (large intestine) and the prominent expression of **IGHA1** and **IGHA2**, the most likely specific subtype is **IgA-secreting Plasma Cells (Mucosal Plasma Cells)**. ### 6. Provide a Concise Summary of Your Analysis The cell cluster exhibits a highly specific gene expression profile dominated by immunoglobulin heavy chain (IGHG1, IGHA1, IGHM, IGHG3) and light chain (IGLL5, IGLC3, IGLC2, IGKC, IGLV6-57, IGKV4-1, IGLV3-1, IGKV1-5, IGLV2-11, IGKV3-20) genes, along with **JCHAIN**, which is essential for polymeric immunoglobulin assembly and secretion. Key plasma cell-specific markers such as **TNFRSF17 (BCMA)** and **MZB1** are also highly expressed. Given the tissue origin (large intestine), the strong expression of **IGHA1** and **IGHA2** is particularly significant, indicating a primary role in mucosal immunity. This comprehensive marker signature unequivocally identifies the cell cluster as **Plasma Cells**. Specifically, due to the high expression of IgA heavy chains in a mucosal tissue, the most probable subtype is **IgA-secreting Plasma Cells**. FINAL ANNOTATION COMPLETED | Coupling Validator: Validation result: VALIDATION PASSED | Formatting Agent: ```json { ""main_cell_type"": ""Plasma Cell"", ""sub_cell_types"": [""IgA-secreting Plasma Cells"", ""IgG-secreting Plasma Cells"", ""IgM-secreting Plasma Cells""], ""possible_mixed_cell_types"": [] } ```"
transit amplifying cell of large intestine,Proliferating Epithelial Cells,"Intestinal Transit-Amplifying (TA) Cells, Intestinal Stem Cells (ISCs), Early Progenitor Cells",,50,"HJURP, UBE2C, CENPA, PBK, AURKB, DLGAP5, CKAP2L, KIF2C, KIF15, BIRC5, SPC25, ASPM, KIF18B, CEP55, DEPDC1, MKI67, CDC45, CDCA5, TOP2A, PCLAF, MND1, RRM2, ZNF695, CCNB2, NUF2, SKA3, SPC24, DTL, PKMYT1, CDCA3, TTK, DIAPH3, PLK1, IQGAP3, CDK1, TK1, POLQ, GTSE1, OIP5, FOXM1, TROAP, SKA1, NEK2, CDC25C, NCAPG, PIMREG, GINS2, RAD51AP1, CDT1, CCNA2",1,google/gemini-2.5-flash,openrouter,large intestine,human,N/A,"Final Annotation Agent: Okay, I will analyze the provided list of highly expressed markers from a single-cell cluster in human large intestine tissue to identify the cell type. Here's my step-by-step analysis: ### Step 1: List the Key Functional Markers The vast majority of the genes in this list are intimately involved in cell cycle progression, DNA replication, and mitosis. This immediately points towards a highly proliferative cell population. * **Cell Cycle Regulation & Mitosis:** * **UBE2C:** Ubiquitin-conjugating enzyme E2 C, crucial for mitotic progression by regulating the degradation of mitotic cyclins. * **CENPA:** Centromere protein A, a histone H3 variant essential for kinetochore assembly and chromosome segregation. * **PBK (TOPK):** PDZ binding kinase, involved in cell proliferation, survival, and mitosis. * **AURKB:** Aurora kinase B, a key regulator of mitosis, involved in chromosome alignment, segregation, and cytokinesis. * **DLGAP5:** DLG associated protein 5, a spindle-associated protein essential for mitotic spindle organization and chromosome segregation. * **CKAP2L:** Cytoskeleton associated protein 2 like, involved in microtubule organization and cell division. * **KIF2C (MCAK):** Kinesin family member 2C, a microtubule depolymerase critical for chromosome segregation and spindle dynamics. * **KIF15:** Kinesin family member 15, involved in mitotic spindle assembly and maintenance. * **BIRC5 (Survivin):** Baculoviral IAP repeat containing 5, an anti-apoptotic protein highly expressed in proliferating cells, also involved in mitosis. * **SPC25, SPC24:** Spindle pole body component 25/24 homolog, part of the NDC80 kinetochore complex, essential for chromosome segregation. * **ASPM:** Abnormal spindle microtubule assembly, a key regulator of spindle pole integrity and neurogenesis, also involved in general cell proliferation. * **KIF18B:** Kinesin family member 18B, involved in chromosome congression and segregation during mitosis. * **CEP55:** Centrosomal protein 55kDa, involved in cytokinesis. * **DEPDC1:** DEP domain containing 1, a cell cycle-regulated protein involved in cell proliferation. * **MKI67 (Ki-67):** Marker of proliferation Ki-67, a classic and widely used marker for actively proliferating cells. Its high expression is a strong indicator of cell division. * **CDC45:** Cell division cycle 45, essential for initiation of DNA replication. * **CDCA5 (Sororin):** Cell division cycle associated 5, involved in sister chromatid cohesion. * **TOP2A:** DNA topoisomerase II alpha, essential for DNA replication, chromosome condensation, and segregation. * **PCLAF (PCNA-associated factor):** PCNA-associated factor, involved in DNA replication and repair. * **MND1:** Meiotic nuclear division 1, involved in homologous recombination and DNA repair, particularly during meiosis but also in mitotic cells. * **RRM2:** Ribonucleotide reductase M2, essential for DNA synthesis by providing dNTPs. * **CCNB2:** Cyclin B2, a mitotic cyclin that regulates entry into and progression through mitosis. * **NUF2:** NDC80 kinetochore complex component, essential for chromosome segregation. * **SKA3, SKA1:** Spindle and kinetochore associated complex subunit 3/1, involved in stable kinetochore-microtubule attachments. * **DTL (CDT2):** Denticleless E3 ubiquitin protein ligase homolog, involved in DNA replication and cell cycle control. * **PKMYT1:** Protein kinase, membrane associated tyrosine/threonine 1, a mitotic kinase that inhibits CDK1. * **CDCA3:** Cell division cycle associated 3, involved in mitotic progression. * **TTK (MPS1):** TTK protein kinase, a key component of the spindle assembly checkpoint. * **DIAPH3:** Diaphanous related formin 3, involved in cytokinesis. * **PLK1:** Polo-like kinase 1, a master regulator of multiple mitotic events. * **IQGAP3:** IQ motif containing GTPase activating protein 3, involved in cell proliferation and migration. * **CDK1 (CDC2):** Cyclin dependent kinase 1, the master regulator of mitotic entry and progression. * **TK1:** Thymidine kinase 1, involved in DNA synthesis. * **POLQ:** DNA polymerase theta, involved in DNA repair, particularly alternative end-joining. * **GTSE1:** G2 and S-phase expressed 1, involved in cell cycle regulation. * **OIP5:** Opa interacting protein 5, involved in mitotic spindle formation. * **FOXM1:** Forkhead box protein M1, a transcription factor crucial for the expression of many genes involved in cell cycle progression and mitosis. Often referred to as the ""master regulator of mitosis."" * **TROAP:** Trophinin associated protein, involved in cytokinesis. * **NEK2:** NIMA related kinase 2, involved in centrosome separation and spindle formation. * **CDC25C:** Cell division cycle 25C, a phosphatase that activates CDK1. * **NCAPG:** Non-SMC condensin I complex subunit G, part of the condensin complex involved in chromosome condensation. * **PIMREG:** PIM1 proto-oncogene, serine/threonine kinase regulator, involved in cell cycle progression. * **GINS2:** GINS complex subunit 2, essential for DNA replication initiation and elongation. * **RAD51AP1:** RAD51 associated protein 1, involved in DNA repair and homologous recombination. * **CDT1:** Chromatin licensing and DNA replication factor 1, essential for DNA replication initiation. * **CCNA2:** Cyclin A2, involved in both S-phase and M-phase progression. * **Other:** * **HJURP:** Holliday junction recognition protein, involved in CENP-A deposition at centromeres, crucial for chromosome segregation. **Summary of Functional Markers:** The overwhelming majority of these markers are directly involved in DNA replication, cell cycle progression (especially S and M phases), chromosome dynamics, and cytokinesis. This is a classic signature of highly proliferating cells. ### Step 2: List the Key Cell Type Markers Given the functional markers, the primary ""cell type marker"" here is the *proliferative state itself*. There are no specific lineage-defining markers (e.g., epithelial, immune, stromal, neuronal) in this list. Instead, the markers define a functional state common to many cell types that are actively dividing. However, in the context of the large intestine, we need to consider which cell types are known to be highly proliferative. * **MKI67 (Ki-67):** As mentioned, this is the quintessential marker for proliferating cells. Its presence at the top of the list (ranked by expression intensity) strongly indicates a rapidly dividing population. * **FOXM1:** A transcription factor that drives the expression of many mitotic genes, further reinforcing the proliferative nature. There are no markers like *EPCAM, KRT8, KRT18* (epithelial), *CD3D, CD4, CD8A* (T cells), *CD19, CD79A* (B cells), *CD68, CD14* (macrophages), *ACTA2, MYH11* (smooth muscle), or *COL1A1, DCN* (fibroblasts). This absence, combined with the strong proliferative signature, suggests we are looking at a population of cells that are *actively dividing* within a tissue, rather than a terminally differentiated, quiescent cell type. ### Step 3: Cross-reference Known Databases Cross-referencing these markers with scRNA-seq databases (e.g., Human Cell Atlas, PanglaoDB, CellMarker, specific large intestine atlases) consistently points to ""proliferating cells"" or ""cycling cells."" * **MKI67, TOP2A, BIRC5, UBE2C, AURKB, CDK1, CCNB2, RRM2, TK1, CDC45, PLK1, FOXM1** are all canonical markers for proliferating cells across various tissues and species. * In the large intestine, the primary highly proliferative cell population is the **intestinal stem cells (ISCs)** and their immediate **progenitor/transit-amplifying (TA) cells** located in the crypts of Lieberkühn. These cells continuously divide to replenish the intestinal epithelium. * While other cell types can proliferate (e.g., activated immune cells, fibroblasts during repair), the sheer breadth and intensity of these mitotic markers strongly argue for a dedicated, rapidly dividing epithelial lineage. ### Step 4: Determine the Most Probable General Cell Type Based on the overwhelming evidence from the functional markers, the most probable general cell type is **Proliferating Epithelial Cells**. The presence of a comprehensive set of cell cycle and mitotic genes, including master regulators (FOXM1, CDK1, PLK1) and classic proliferation markers (MKI67, BIRC5, TOP2A), leaves little doubt that this cluster represents cells actively undergoing division. In the large intestine, the primary source of such proliferation is the epithelial lineage, specifically the stem and progenitor cells. ### Step 5: Identify the Top 3 Most Probable Sub Cell Types Given the general cell type of Proliferating Epithelial Cells in the large intestine, the sub-types relate to the stages of differentiation and proliferation within the crypt. 1. **Intestinal Transit-Amplifying (TA) Cells:** * **Reasoning:** TA cells are highly proliferative, undergoing rapid rounds of division as they migrate up the crypt-villus axis. They express high levels of cell cycle genes, similar to what is observed here. They are the most abundant proliferating population in the crypt. The sheer number and diversity of mitotic markers strongly align with the rapid expansion phase characteristic of TA cells. * **Marker Alignment:** All the listed markers are highly consistent with TA cells. 2. **Intestinal Stem Cells (ISCs):** * **Reasoning:** ISCs (e.g., Lgr5+ stem cells) are at the base of the crypt and are responsible for self-renewal and generating all other epithelial lineages. They are also highly proliferative, albeit often at a slightly slower rate or with more regulated division than their immediate TA progeny. Many of the listed markers are also expressed in ISCs. * **Marker Alignment:** While ISCs are proliferative, some studies suggest TA cells might have even higher *overall* expression of many cell cycle genes due to their rapid, committed division cycles. However, without specific ISC markers (e.g., *LGR5, OLFM4, ASCL2*), it's difficult to definitively separate them from TA cells based solely on proliferation markers. The current list is consistent with both, but the breadth suggests a population beyond just the quiescent or slowly cycling stem cells. 3. **Early Progenitor Cells (committed to specific lineages, but still dividing):** * **Reasoning:** As TA cells differentiate, they commit to specific lineages (e.g., enterocytes, goblet cells, enteroendocrine cells). In their early stages of commitment, they may still undergo a few rounds of division before terminal differentiation. This would still involve the expression of many of the listed cell cycle genes. * **Marker Alignment:** This is a less distinct category and largely overlaps with TA cells. It represents the tail end of the proliferative phase before terminal differentiation. **Most Likely Subtype:** Based on the comprehensive and intense expression of a wide array of cell cycle and mitotic genes, the most likely subtype is **Intestinal Transit-Amplifying (TA) Cells**. These cells are characterized by their rapid and extensive proliferation to generate the vast number of cells needed to replenish the intestinal epithelium. While ISCs are also proliferative, the sheer scale of the mitotic machinery indicated by this marker list points more strongly to the highly active TA population. ### Step 6: Provide a Concise Summary of Your Analysis The single-cell cluster from human large intestine tissue is unequivocally identified as **Proliferating Epithelial Cells**. The marker list is dominated by genes critically involved in DNA replication, cell cycle progression (S and M phases), chromosome dynamics, and cytokinesis. Key markers such as MKI67, TOP2A, BIRC5, UBE2C, AURKB, CDK1, CCNB2, RRM2, TK1, CDC45, PLK1, and the master mitotic transcription factor FOXM1 are all highly expressed, indicating a population undergoing rapid cell division. In the context of the large intestine, this signature is characteristic of the epithelial lineage responsible for continuous tissue renewal. The top three most probable sub-cell types are: 1. **Intestinal Transit-Amplifying (TA) Cells** (Most Likely) 2. **Intestinal Stem Cells (ISCs)** 3. **Early Progenitor Cells** The most likely specific subtype is **Intestinal Transit-Amplifying (TA) Cells**, given the extensive and high expression of a broad range of mitotic machinery, which is characteristic of their rapid and numerous divisions to expand the epithelial population. FINAL ANNOTATION COMPLETED | Coupling Validator: Validation result: VALIDATION PASSED | Formatting Agent: ```json { ""main_cell_type"": ""Proliferating Epithelial Cells"", ""sub_cell_types"": [""Intestinal Transit-Amplifying (TA) Cells"", ""Intestinal Stem Cells (ISCs)"", ""Early Progenitor Cells""], ""possible_mixed_cell_types"": [] } ```"
